FinEdge Labs
B

BAX

BAXReviewed
3 segments tracked|8 years of data|Annual (10-K)
Total Revenue
$10.9B2.8%
FY2025
Operating Segments
3
Active segments
Blended Margin
15.0%
Operating margin
Highest Margin
18.3%
Medical Products And Therapies
Segment Shift

Medical Products And Therapies has grown from 0.0% to 48.8% of total revenue since FY2018, with 18.3% operating margins. Meanwhile, Healthcare Systems And Technologies is the fastest growing at +4.1% YoY.

Segment Revenue Over Time

Revenue Mix

Segment Breakdown — FY2025

SegmentRevenueOp. IncomeMargin% of TotalYoY
Medical Products And Therapies$5.3B$970M18.3%48.8%+1.8%
Healthcare Systems And Technologies$3.1B$441M14.4%28.3%+4.1%
Pharmaceuticals$2.5B$222M8.9%22.9%+3.4%

Want more? Unlock the full analysis.

Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.

Get Started Free